Clinical Trial Update: FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial of roxadustat (FG-4592) for anemia in chronic kidney disease not on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia | Phase 3 | Status: COMPLETED